|
The Technology
Augurex’s lead technology, AGX-020 is a novel biomarker of arthritis. It
is a protein that is normally present inside of cells but in people with
arthritis it is released into the joints and causes harmful molecules to
breakdown joint tissue. Scientists have found that it is not only present in
the joints of arthritis patients but that it is measurable in blood which
makes this protein particularly useful for managing arthritis patients and
following their disease progression through a simple blood test.
|
